Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Caribou Bioscience (CRBU) stocks in Canada
Learn how to easily invest in Caribou Bioscience stocks.
Caribou Bioscience is a biotechnology business based in the US. Caribou Bioscience stocks (CRBU.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23.23 – a decrease of 15.41% over the previous week. Caribou Bioscience employs 0 staff and has a trailing 12-month revenue of around $8 million.
How to buy shares in Caribou Bioscience
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRBU – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Caribou Bioscience stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
Caribou Bioscience stock price (NASDAQ:CRBU)Use our graph to track the performance of CRBU stocks over time.
Caribou Bioscience shares at a glance
|Latest market close||$10.87|
|52-week range||$12.20 - $32.65|
|50-day moving average||$17.81|
|200-day moving average||$21.14|
|Wall St. target price||$31.20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.37|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Caribou Bioscience price performance over time
|1 week (2022-01-12)||-15.41%|
|1 month (2021-12-17)||-31.20%|
|3 months (2021-10-19)||-45.57%|
|6 months (2021-07-15)||N/A|
|1 year (2021-01-15)||N/A|
|2 years (2020-01-15)||N/A|
|3 years (2019-01-15)||N/A|
|5 years (2017-01-15)||N/A|
Caribou Bioscience financials
|Revenue TTM||$8 million|
|Gross profit TTM||$-22,064,000|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$773.5 million|
TTM: trailing 12 months
Caribou Bioscience share dividends
We're not expecting Caribou Bioscience to pay a dividend over the next 12 months.
Caribou Bioscience overview
Caribou Biosciences, Inc. , a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. Caribou Biosciences has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California. .
Stocks similar to Caribou Bioscience
Frequently asked questions
Caribou Bioscience in the news
Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Caribou Biosciences : Appoints Syed Rizvi, M.D., as Chief Medical Officer - Form 8-K
More guides on Finder
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.
Ask an Expert
You must be logged in to post a comment.